DRS B3

General Information


DRACP ID  DRACP01095

Peptide Name   DRS B3

Sequence  ALWKNMLKGIGKLAGQAALGAVKTLVGA

Sequence Length  28

UniProt ID  P81485  P83641  C0HLD2 

PubChem CID  Not available

Origin  Dermaseptins B

Type  Native peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
MCF-7 Invasive breast carcinoma of no special type Carcinoma Cytotoxicity=12 µM Thymidine Incorporation assay 6 h 1

Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antimicrobial



Structure Information


PDB ID  Not available

Predicted Structure  DRACP01095

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C127H219N35O32S

Absent amino acids  CDEFHPRSY

Common amino acids  A

Mass  326224

Pl  11.28

Basic residues  4

Acidic residues  0

Hydrophobic residues  15

Net charge  4

Boman Index  2089

Hydrophobicity  65.71

Aliphatic Index  125.71

Half Life 
  Mammalian: 4.4 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  5500

Absorbance 280nm  203.7

Polar residues  7

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 9614066

Title  Structure, synthesis, and molecular cloning of dermaseptins B, a family of skin peptide antibiotics

Doi 10.1074/jbc.273.24.14690

Year  1998

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.